Technion Human Health Initiative

Technion and Rambam Sign Long-Term Collaboration Agreement for the Wolfe Center for Translational Medicine and Engineering

Fast tracking ideas to real world-solutions
On September 10, 2026, on the eve of the Jewish New Year, The President of the Technion, Prof. Uri Sivan and the CEO of Rambam Health Care Campus, Dr. Michal Mekel, signed an agreement on the operation of the Wolfe Center for Translational Medicine and Engineering, marking a milestone in the realization of this ambitious initiative.

Why Some Cancer Patients Respond to Immunotherapy While Others Don’t May Depend on What Happens Early in Treatment

Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients apart before therapy begins. Why does immunotherapy succeed for some and fail for others

About the initiative

Human health stands out as one of humanity's grand challenges for the 21st century and beyond. Like other grand challenges, the advancement of human health requires multidisciplinary efforts – the fusion of life, physical, data and behavioral sciences, clinical practices, engineering and design.

To this end, the Technion launched the Technion Human Health Initiative (THHI) an institution-wide, comprehensive program that aims to address this challenge in its broadest terms